Bioluminescence Ventures is a biotechnology venture firm investing in Drug Discovery Platforms (Oncology, Immunology, Neuroscience, Genetic Diseases), Applied Biology Platforms, and Computational Biology Platforms. The firm has AUM of $550M+ with offices in San Francisco and Cambridge (MA). 

Biomedical research is entering a Golden Age of Discovery – industrialized by HW/SW technologies, powered by longitudinal multi-modal data sets, and translated into novel therapies / therapeutic modalities by a new generation of multidisciplinary scientific founders. Bioluminescence was conceptualized and launched to potentiate this next generation of translational founders. Patient impact is our guiding light, and we see this light radiating from exceptional translational founders. Our growing team of multidisciplinary biotechnology researcher-operator-investors seek to earn trust through a shared understanding of the science and a shared vision for its potential to address unmet clinical needs. We seek to provide technical support as they translate and develop their science. We seek to provide financing support through the long and arduous journey. We also seek to provide business advisory and development support as the science matures toward co-development and co-commercialization partnerships. By obsessively and comprehensively meeting the needs of our founders, we aim to maximize their downstream impact on patients. We aim to make their light shine brighter.

For more information, please visit Bioluminescence.com.

Bioluminescence Ventures

Looking forward to a productive #JPM2023! If you'd like to connect or learn more about Bioluminescence Ventures, please reach out to info@bioluminescence.com 

#bioluminescence #biotechnology #JPMWeek

Fastly Hosted

Partner

Andy Seid

Negin Mokhtari

Kouki Harasaki

Managing Partner

Early Stage Venture Investors with Investments in Texas

Venture Capital Investors (Top 10K)

San Francisco Bay Area Early Stage Venture Investors

San Francisco Bay Area Investors with Funds Raised in 2023

Bioluminescence is a leading US biotechnology venture capital firm investing in the future of medicine. We are inspired by the accelerating pace of biomedical innovation and its recent impact on humanity. We are mission-driven – investing our time, energy, and capital into translating transformative science into next-generation medicines that will impact patients. We believe that, as long as we continue to succeed in this endeavor, then strong financial returns will follow. The firm focuses investments on four areas: Breakthrough Biology, Drug Discovery Platforms, Genetic Medicines Platforms, and Computational Biology Platforms.

Bioluminescence Ventures Fund I, L.P.

Bioluminescence Ventures Fund II, L.P.

San Francisco

California

United States

North America

Bioluminescence Ventures taps Murray as senior partner

Bioluminescence Ventures Reveals Partners and Investment Management Team

Bioluminescence Ventures Emerges from Stealth with $477M AUM

VC Firm Bioluminescence Ventures Launches with $477M in Assets

Glowee specializes in bioluminescent technologies for various applications, including lighting solutions.

Glowee

Chelsea Technologies is involved in the development and application of bioluminescence technologies for environmental monitoring and research.

Chelsea Technologies

Nanolight specializes in the development of bioluminescence technology for cellular research and metabolic studies.

Nanolight

Merkel provides reliable and affordable bioluminescence assay kits along with technical expertise for optimal usage.

Merkel

Nyoka Design Labs produces biodegradable light wands with bioluminescence, aiming to replace toxic chemical glow sticks.

Nyoka Design Labs

This company uses bioluminescent bacteria to produce lighting solutions for events, communication agencies, and shop windows.

Bioluminescent Bacteria Solutions

A company that likely specializes in the research, development, and application of bioluminescence technologies. Bioluminescence refers to the production and emission of light by living organisms. This can be applied in various fields such as biotechnology, medical diagnostics, environmental monitoring, and research.

Bioluminescence

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 1:29 PM	2ca194cd
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	f7822493
crunchbase profile	general	Nov 25, 2024 9:47 AM	cc8938aa
li profile	general	May 16, 2024 1:29 PM	364285c3
translate crunchbase fundingrounds	general	Nov 25, 2024 2:07 PM	5a9b9fc2
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:BIOLUMINESCENCE

Bioluminescence